Federal Agencies Engaged in the Action Plan
The National Viral Hepatitis Action Plan was developed collaboratively by partners from the U.S. Departments of Health and Human Services, Housing and Urban Development, Justice, and Veterans Affairs with input from nonfederal stakeholders from a variety of sectors. Representatives of those federal agencies serve on the Viral Hepatitis Implementation Group (VHIG), which confers regularly, monitors implementation of the Action Plan, coordinates messaging about viral hepatitis in the U.S., and seeks to optimize new opportunities as they arise.
- Agency for Healthcare Research and Quality (AHRQ)
- Centers for Disease Control and Prevention (CDC)
- Division of Viral Hepatitis (DVH)
- Centers for Medicare & Medicaid Services (CMS)
- Food and Drug Administration (FDA)
- Health Resources and Services Administration (HRSA)
- Indian Health Service (IHS)
- National Institutes of Health (NIH)
- National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
- National Institute on Drug Abuse (NIDA)
- Office of Intergovernmental and External Affairs (IEA)
- Office of the Assistant Secretary for Health (OASH)
- Office of HIV/AIDS and Infectious Disease Policy (OHAIDP)
- National Vaccine Program Office (NVPO)
- Office of Disease Prevention and Health Promotion (ODPHP)
- Office of Minority Health (OMH)
- Office of Population Affairs (OPA)
- Office of the Surgeon General (OSG)
- Office on Women’s Health (OWH)
- Regional Health Administrators (RHA)
- Office of the National Coordinator for Health Information Technology (ONC)
- Substance Abuse and Mental Health Services Administration (SAMHSA)
- Office of Special Needs Assistance Programs
- Federal Bureau of Prisons (FBOP)
- Civil Rights Division (CRT)
- Patient Care Services (PCS)
Each of these agencies and offices is represented on the cross-agency work group that developed and is tasked with coordinating and monitoring implementation of the Action Plan. You can read about some of their activities in our blog. Annual progress reports are produced that highlight many more of the activities these federal partners have undertaken. Read progress reports from prior years.
By providing a comprehensive framework for our national response to hepatitis B and C, the Action Plan seeks to align the efforts of all stakeholders—federal and nonfederal alike—as well as facilitate new and expanded collaborative activities among stakeholders.
Among the activities being undertaken collaboratively by several of the federal agencies is the Hepatitis C Medicaid Affinity Group (Affinity Group). Launched in December 2017, the Affinity Group supports collaboration among states to improve outcomes among people enrolled in state Medicaid programs who have hepatitis C infection.